Curetis

55 articles about Curetis

• OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement

  8/3/2023

  OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported that its German subsidiary Curetis GmbH has signed an extended and continued research and development collaboration agreement with FIND.

• OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia

  1/5/2021

  OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced that its subsidiary Curetis GmbH has entered into a distribution agreement with Annar Health Technologies for Colombia.

• OpGen Subsidiary Curetis GmbH and Karolinska Institutet Collaborate in Study of Bacterial Co-Infections in COVID-19 Pneumonia Patients

  4/21/2020

  Investigator initiated study at Sweden’s Karolinska Institutet to test COVID-19 pneumonia patients with Unyvero HPN panel for bacterial co-infections

• OpGen and Curetis Successfully Close their Business Combination Transaction

  4/1/2020

  OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced that the business combination between Curetis and OpGen has successfully closed on April 1, 2020.

• OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with CuretisShareholder proxy vote stands at 97% of the required quorum with support for the transaction at over 95%

  3/19/2020

  OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced an update on shareholder proxy voting in relation to the business combination with Curetis.

• OpGen Achieves Key Milestone in Planned Business Combination with Curetis

  1/28/2020

  Special meetings of OpGen and Curetis shareholders are scheduled for March 10, 2020, at 10:00am ET and 1:00pm CET, respectively

• QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens

  2/18/2019

  Developing Sample to Insight solutions to accelerate research on growing public health threat

• Curetis Unyvero HPN Receives Approval in Singapore

  2/8/2018

  With this approval, Unyvero HPN is now fully registered as a Class C IVD medical device with the Singapore Medical Device Register.

• Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology

  1/11/2018

  To this end, Curetis has signed a Supply and Authorization Agreement as well as a further R&D Collaboration and Service Agreement with MGI.

• Curetis Initiates U.S. FDA Study for Unyvero Invasive Joint Infections Cartridge

  10/24/2017

  Curetis N.V. today announced it has started collecting patient samples for a multi center FDA study for its Unyvero IJI Cartridge for the detection of invasive joint infections.

• MGI And Curetis To Collaborate On NGS-Based Infectious Disease Diagnostics

  9/13/2017

• Curetis Partners With Biotest AG To Support Academic PEPPER Pentaglobin Peritonitis Trial With Unyvero IAI Application

  8/15/2017

• Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking

  4/21/2017

• Curetis Starts Subsidiary Ares Genetics To Advance Genetic Antibiotic Resistance Testing

  4/6/2017

• Curetis’ Global Installed Base Expanding To Over 150 Unyvero Analyzers

  2/2/2017

• Curetis Files for U.S. FDA Clearance For Unyvero Platform And LRT Application Cartridge

  1/9/2017

• Curetis Announces Positive Top Line Data From U.S. FDA Trial

  10/25/2016

• Curetis Appoints Christopher M. Bernard As Chief Executive Officer Of Newly-Formed U.S. Subsidiary

  7/6/2016

• Curetis Completes Sample Enrollment In Unyvero FDA Trial In Lower Respiratory Tract Infections

  6/29/2016

• Curetis Announces Excellent Study Data And Multi-Region Launch Of Unyvero BCU Blood Culture Application Cartridge

  6/17/2016